openPR Logo
Press release

In Vivo Contract Research Organization (CRO) Market Share Growing Rapidly with Recent Trends and Outlook 2024

06-28-2024 11:56 AM CET | IT, New Media & Software

Press release from: Reports and Data

In Vivo Contract Research Organization (CRO) Market Share

The In Vivo Contract Research Organization (CRO) market is anticipated to witness significant growth in the coming years, fueled by a confluence of factors. This press release delves into the market landscape, exploring trends, drivers, restraints, and opportunities that will shape the future of this dynamic sector.

Market Overview and Trends

The In Vivo CRO market was valued at USD 3.61 billion in 2022 and is projected to reach a staggering USD 6.44 billion by 2028, exhibiting a Compound Annual Growth Rate (CAGR) of 8.2%. This growth can be attributed to the increasing complexity of drug development processes, prompting pharmaceutical and biotechnology companies to outsource these specialized services to CROs. Additionally, the rising prevalence of chronic diseases and the urgent need for innovative therapies are driving the demand for in vivo studies, further propelling market expansion.

Claim Your FREE Sample Copy with Table of content@ https://www.reportsanddata.com/download-free-sample/1634

Key Drivers

Outsourcing Surge: The pharmaceutical industry is increasingly outsourcing drug development activities to CROs to capitalize on their expertise, cost-effectiveness, and global reach.

Mounting Disease Burden: The growing prevalence of chronic diseases like cancer, diabetes, and neurological disorders necessitates the development of novel treatments, translating into a higher demand for in vivo studies.

Focus on R&D: Pharmaceutical and biotechnology companies are channeling significant investments into research and development (R&D) activities, fueling the demand for CRO services.

Technological Advancements: The adoption of advanced technologies like gene editing and artificial intelligence (AI) in drug discovery is streamlining in vivo studies, enhancing their efficiency and accuracy.

Restraints and Challenges

Stringent Regulations: Stringent regulatory requirements for drug development pose a challenge for CROs, demanding adherence to complex protocols and extending timelines.

Ethical Concerns: Ethical considerations surrounding animal testing can impede in vivo research and influence public perception.

Skilled Workforce Shortage: The availability of qualified personnel with expertise in conducting in vivo studies remains a limiting factor.

Growth Opportunities

Emerging Markets: The burgeoning pharmaceutical industries in Asia-Pacific and Latin America present lucrative growth avenues for CROs.

Niche Therapeutic Areas: Specializing in niche therapeutic areas like oncology and immuno-oncology can enable CROs to cater to unmet medical needs and capture a larger market share.

Strategic Partnerships: Collaborations between CROs and pharmaceutical companies can foster innovation and accelerate drug development timelines.

Key Market Insights

North America currently dominates the In Vivo CRO market, primarily due to the presence of established pharmaceutical giants and a robust healthcare infrastructure.

The oncology segment within the In Vivo CRO market is anticipated to witness significant growth owing to the rising incidence of cancer and the burgeoning pipeline of oncology drugs.

SWOT Analysis

Strengths: Expertise, global reach, cost-effectiveness

Weaknesses: Regulatory hurdles, ethical concerns

Opportunities: Emerging markets, niche areas, strategic partnerships

Threats: Skilled workforce shortage, technological disruptions

For more informative information, please visit us @ https://www.reportsanddata.com/report-detail/in-vivo-cro-market

Latest Strategic Developments, Mergers & Acquisitions

In November 2020, Bioanalytical Systems, Inc. launched their new contract research service brand named Inotiv. Inotiv started representing the union of the company's Seventh Wave Laboratories & Smithers Avanza Toxicology Services working In Vivo Toxicology, pharmacology, bioanalysis, drug metabolism, and pharmacokinetic solutions.

In April 2020, PAREXEL International Corporation announced it has been ranked #1 among global Clinical Research Organizations (CROs) for service provider leadership in Phase II/III clinical research according to a global survey of pharmaceutical and biotechnology companies by Industry Standard Research (ISR)

Companies considered and profiled in this market study
American Preclinical Services, LLC, BTS Research, Charles River Laboratories, Chiltern International Ltd., Crown Bioscience, Eurofins Scientific, Evotec, ICON PLC, INC Research, inVentiv Health, Parexel International, Pharmaceutical Product Development, LLC (PPD), PRA Health Sciences, Quintiles, Taconic Biosciences and Theorem Clinical Research, others are leading players involved on the global In vivo CRO market.

Segments covered in the report
This report forecasts revenue growth at a global, regional & country level, and provides an analysis of the market trends in each of the sub-segments from 2020 to 2028. The scope of the report can be defined as:

For the purpose of the study, this report segments the Global In vivo CRO Market on the basis of type, GLP type, indication and the regional outlook at a global, regional & country level, and provides an analysis of the market trends in each of the sub-segments from 2020 to 2026:

Type Outlook (Revenue: USD Billion; 2018-2028)
Rodent-Based

Rats

Mice

Others

Non-Rodent Based

Hamsters

Guinea Pigs

Others

GLP Type Outlook (Revenue: USD Billion; 2018-2028)
Non-GLP

In House

Outsourcing

GLP Toxicology

In House

Outsourcing

Indication Outlook (Revenue: USD Billion; 2018-2028)
Autoimmune/Inflammatory Conditions

Rheumatoid Arthritis

Multiple Sclerosis

Osteoarthritis

Irritable Bowel Syndrome

Others

Pain Management

Chronic Pain

Acute Pain

Oncology

Blood Cancer

Solid Tumor

Syngeneic Model

Patient Derived Xenograft

Xenograft

Others

CNS conditions

Epilepsy

Parkinson's Disease

Huntington's Disease

Stroke

Traumatic Brain Injury

ALS

Muscle Regeneration

Others

Diabetes

Obesity

Others

Ask For Customization: https://www.reportsanddata.com/request-customization-form/1634

Contact Us:
John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com

About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client's make a smarter business decision.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release In Vivo Contract Research Organization (CRO) Market Share Growing Rapidly with Recent Trends and Outlook 2024 here

News-ID: 3558172 • Views:

More Releases from Reports and Data

Agricultural chemical demand and vitamin E production sustain cresol consumption as environmental compliance requirements tighten global supply conditions
Agricultural chemical demand and vitamin E production sustain cresol consumption …
The global Cresol market was valued at USD 892.5 Million in 2025 and is projected to reach USD 1.43 Billion by 2035, registering a revenue CAGR of 4.8% during the forecast period, according to the latest analysis by Reports and Data. New York, June 22, 2026 - The global Cresol market was valued at USD 892.5 Million in 2025 and is expected to reach USD 1.43 Billion by 2035, growing at
Lightweighting requirements and aerospace production growth increase demand for high-performance PEKK materials
Lightweighting requirements and aerospace production growth increase demand for …
NEW YORK, June 11, 2026-The global PEKK market was valued at USD 1.43 Billion in 2025 and is expected to reach USD 3.67 Billion by 2035. Demand is increasing as aerospace, automotive, medical, and industrial manufacturers seek lightweight materials that can withstand high temperatures and harsh operating environments. The shift toward fuel-efficient aircraft and electric vehicles is creating sustained demand for advanced thermoplastics with superior mechanical performance. According to the
Retail personalization trends sustain demand for instant photo printing despite growth in digital image storage
Retail personalization trends sustain demand for instant photo printing despite …
NEW YORK, June 11, 2026-The global Photo Printing Kiosk market was valued at USD 612.4 Million in 2025 and is expected to reach USD 1028.7 Million by 2035. Demand is being supported by continued consumer interest in personalized photo products and the expansion of self-service retail technologies. Retailers are deploying photo printing kiosks to improve customer engagement while creating additional revenue streams through customized prints, photo gifts, and instant photo
Rising vector-borne disease outbreaks increase mosquito control spending across public health and urban infrastructure programs
Rising vector-borne disease outbreaks increase mosquito control spending across …
NEW YORK, June 11, 2026-The global Mosquito Control Market was valued at USD 5.43 Billion in 2025 and is expected to reach USD 9.18 Billion by 2035. Demand is increasing as governments and public health agencies expand mosquito surveillance and vector control programs to address the growing incidence of mosquito-borne diseases. Urban population growth and changing climatic conditions are creating favorable breeding environments for mosquitoes across many regions. According to

All 5 Releases


More Releases for CRO

Cronos (CRO) Expands Across Dubai as AlphaPepe Chases the 100x Run CRO Already M …
Cronos just scored a real-world win, expanding its footprint across Dubai as the region keeps opening doors for crypto-native infrastructure. It is the kind of headline that makes CRO holders feel validated. It is not the kind of headline that creates a fresh 100x. That window already closed for CRO years ago, back when it was a small-cap exchange token nobody outside crypto Twitter had heard of AlphaPepe https://www.alphapepe.io/ is sitting
Contract Research Organization (CRO) Research: China CRO market size is projecte …
QY Research Inc. (Global Market Report Research Publisher) announces the release of 2025 latest report "Contract Research Organization (CRO)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031". Based on current situation and impact historical analysis (2020-2024) and forecast calculations (2025-2031), this report provides a comprehensive analysis of the global Wire Drawing Dies market, including market size, share, demand, industry development status, and forecasts for the next few
Global Contract Research Organization (CRO) Services Market
According to a new market research report published by Global Market Estimates, the Global Contract Research Organization (CRO) Services Market is expected to grow at a CAGR of 10.2% from 2023 to 2028. The growth of the contract research organization (CRO) Services Market is fuelled by factors including the rising preference for outsourcing clinical trials, increasing investments in research and development by pharmaceutical and biopharmaceutical companies, the growing complexities in drug
Contract Research Organization (CRO) Services Market - Efficiency, Expertise, Ex …
Newark, New Castle, USA: The "Contract Research Organization (CRO) Services Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Contract Research Organization (CRO) Services Market: https://www.growthplusreports.com/report/contract-research-organization-cro-services-market/7630 This latest report
Biopharmaceutical CMO and CRO Market
The Biopharmaceutical CMO and CRO Market crossed US$ 32.25 billion in 2022 and is expected to hit US$ 54.13 billion by 2030, recording a CAGR of 6.5% during the forecast period Pharmaceutical and biotech companies focus on R&D activities to innovate new molecules and therapeutic platforms to deal with chronic diseases and rare ailments; they also extensively invest in R&D activities to develop various therapeutic applications with strong medical and commercial
Pracedo Promote Ellie Copp To CRO
Pracedo, a Mashfrog Group company that provides Salesforce consultancy and digital transformation to charities, NGOs, and enterprise customers, promotes Ellie Copp to Chief Revenue Officer. Pracedo announced Ellie Copp as its new Chief Revenue Officer (CRO). Ellie joined Pracedo in 2019 and most recently held the position of Sales and Marketing Director. As CRO, she will continue to lead the commercial teams by overseeing all revenue-generating activities as Pracedo continues